The nucleoside adenosine has increasingly been recognised to be useful in the treatment and diagnosis of cardiac arrhythmias. '-5 The most recent articles of Rankin et al6 and Till et al7 confirm this and provide further evidence of the usefulness and applicability of giving intravenous boluses of adenosine as a therapeutic and diagnostic tool in the short term management of supraventricular arrhythmias.
An understanding of the cellular electrophysiological effects of adenosine was vital in the development of the clinical use of this nucleoside.8 The potential for developing additional clinical uses for adenosine or related compounds (that is agonists and antagonists) rests on further delineation of the cellular and molecular mechanisms of their action.
Our object is to describe the current knowledge of the cellular electrophysiological actions of adenosine and to provide well established examples in which such knowledge has led to the successful use ofthis nucleoside in the management of cardiac arrhythmias.
Basis of action of adenosine
Adenosine is an endogenous nucleoside whose production is increased in response to stimuli such as hypoxia and ischaemia.8 In addition to its coronary vasodilatory properties, adenosine has considerable electrophysiological effects on the specialised tissues of the heart-that is the sinoatrial and atrioventricular nodes and working myocardium.8 Adenosine induced depression of the pacemaker activity of the sinoatrial node and of atrioventricular nodal transmission is responsible for the negative chronotropic (bradycardia) and dromotropic (atrioventricular block) effects caused by the nucleoside. Thus adenosine regulates atrial and ventricular rates independently of each other. In addition to these effects on the specialised tissues, adenosine produces a concentration-dependent shortening of the action potential and hyperpolarisation in the atrial myocardium-effects that are accompanied by a negative inotropic response.8 On the other hand, in the absence of catecholamine stimulation, adenosine causes no discernible electrophysiological or inotropic effect in ventricular myocardium.89 So adenosine has no effect unless the adenylyl cyclase-cAMP system is first stimulated. However, under conditions of enhanced adenylyl cyclase activity (that is raised concentrations of cAMP), the electrophysiological (including triggered activity) and positive inotropic effects of f adrenergic stimulation are antagonised by adenosine.89
The cellular basis for adenosine's effects in supraventricular tissues is mainly the activation of a specific 
